UK generic use soared in 2013

Generics made up almost 75% of prescriptions in the United Kingdom last year. Medical News Today grabbed the statistic from the Health and Social Care information Centre and said competition among Lipitor generics “delivered the greatest decrease in cost of any medicine over the last year.”

A key term to note for those looking for US parallels is generic competition: The New York Times pointed out earlier this month that generics are a bargain as long as four to five manufacturers are fighting over market share, otherwise generic drug prices can skyrocket, as they have with generic digoxin in the US.

You must be a registered member of MMM to post a comment.

Next Article in Channel


Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.